State Action
CCAGW Urges Minnesota House State and Local Government Finance and Policy Committee to Oppose HF 17
HF 17 would impose price controls on prescription drugs through the establishment of the Prescription Drug Affordability Review Board.
CCAGW Urges Indiana House Government and Regulatory Reform Committee to Support HB 1345
HB 1345 will allow for greater innovation and competition in Missouri by establishing a regulatory sandbox.
CCAGW Urges Missouri House Health and Mental Health Policy Committee to Oppose HB 197
HB 197 would create unnecessary regulatory barriers that will undermine the effectiveness of PBMs in Missouri.
CCAGW Urges North Dakota Senate to Oppose SB 2031
SB 2301 would impose harmful price controls that would exacerbate the problems they are meant to fix.
CCAGW Urges Hawaii House Higher Education and Technology Committee to Oppose HB 1497
HB 1497 will fail to achieve its objective of protecting consumer privacy.
CCAGW Urges Indiana Senate Commerce and Technology Committee to Oppose SB 5
SB 5 will fail to achieve its objective of protecting consumer privacy.
CCAGW Urges Mississippi Senate to Oppose SB 2484
SB 2484 would make changes to the federal 340B drug discount program.
CCAGW Urges New Mexico House Health and Human Services Committee to Oppose HB 51
HB 51 would establish the Prescription Drug Affordability Board, which creates a path for the state to implement harmful price controls.
CCAGW Urges Nebraska Health and Human Services Committee to Oppose LB 200
LB 200 is a dangerous piece of legislation that wastes time and taxpayers money.
CCAGW Urges Missouri House Economic Development Committee to Support HB 268
HB 268 will allow for greater innovation and competition in Missouri by establishing a regulatory sandbox.
CCAGW Urges Minnesota House Commerce, Finance, and Policy Committee to Oppose HF 17
HF 17 would impose price controls on prescription drugs through the establishment of the Prescription Drug Affordability Review Board.
CCAGW Urges North Dakota Senate Human Services Committee to Oppose SB 2031
SB 2301 would impose harmful price controls that would exacerbate the problems they are meant to fix.
